Home/Pipeline/SCiP™

SCiP™

Cerebral Palsy

Pivotal Trial PlannedActive

Key Facts

Indication

Cerebral Palsy

Phase

Pivotal Trial Planned

Status

Active

Company

SpineX

About SpineX

SpineX is a private, clinical-stage medical device company pioneering non-invasive spinal cord neuromodulation. Its two core investigational devices, SCONE™ for neurogenic bladder and SCiP™ for cerebral palsy, have both received FDA Breakthrough Device Designation, highlighting their potential to address significant unmet needs. The company is actively recruiting for a global SCONE™ clinical trial and anticipates initiating a pivotal trial for SCiP™ in 2024, targeting a combined market opportunity exceeding $15 billion.

View full company profile

Therapeutic Areas

Urology Neurology Pediatrics

Other Cerebral Palsy Drugs

Drug	Company	Phase	Status
Cerebral Palsy Program	StemCyte	Clinical Trial	Active
Banked Cord Blood Stem Cells	Cryo-Cell	Clinical Trials	Investigational